Modified-Release Oral Minoxidil for Stable Serum Exposure
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for hair loss, such as topical minoxidil, often result in rapid absorption and short-lived serum concentrations, leading to adverse effects and inefficiencies in hair regrowth promotion.
Innovation Solution
A modified release formulation of minoxidil or its pharmaceutically acceptable salts, designed for oral administration, which releases 50% to 98% of the daily dose within 12 hours, with a Tmax of 30 to 360 minutes and Cmax of 0.25 ng/ml to 20 ng/ml, providing sustained serum levels for effective hair regrowth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If topical minoxidil is used for hair loss treatment, then hair regrowth promotion is achieved, but rapid absorption occurs leading to short-lived serum concentrations and adverse effects
Solution Approach 1:
The patent segments the minoxidil dosage into multiple smaller administrations throughout the day (e.g., every 6-8 hours) rather than a single large dose. This segmentation maintains steady serum concentrations by preventing rapid peaks and troughs, thereby reducing adverse effects while sustaining hair regrowth efficacy.
Solution Approach 2:
The patent implements periodic administration of minoxidil at regular intervals (every 6-8 hours) to maintain consistent serum levels. This periodic dosing strategy prevents the short-lived concentration spikes associated with single-dose regimens, thereby reducing adverse effects while preserving therapeutic effectiveness.
2Ease of operation
If single dose administration is used, then simplicity of dosing is achieved, but therapeutic concentrations are not maintained over extended period
Solution Approach 1:
The patent divides the total daily minoxidil dose into multiple smaller administrations (e.g., 2.5-5 mg every 6-8 hours) to maintain therapeutic serum concentrations throughout the day. This segmentation ensures continuous therapeutic effect while remaining simple to administer.
Solution Approach 2:
The patent ensures continuous therapeutic action by administering minoxidil at regular intervals throughout the day, preventing gaps in therapeutic coverage. This continuous dosing strategy maintains steady serum concentrations, ensuring prolonged hair regrowth efficacy without complex dosing regimens.
3Speed
If rapid absorption formulation is used, then quick onset of action is achieved, but adverse effects increase due to high peak concentrations
Solution Approach 1:
The patent segments the total minoxidil dose into multiple smaller administrations throughout the day, preventing rapid accumulation and high peak concentrations. This segmentation reduces adverse effects while maintaining therapeutic effectiveness through sustained lower-level exposure.
Solution Approach 2:
The patent employs periodic dosing at regular intervals (every 6-8 hours) to achieve gradual, controlled absorption rather than rapid single-dose uptake. This periodic administration prevents dangerous peak concentrations while maintaining continuous therapeutic presence in the system.
Data Source
AI summary
The compositions and methods provided herein include a pharmaceutical formulation for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical formulations for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof and one or more additional active agents. Also provided herein are methods of treating hair loss by administering to a subject in need thereof a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Further provided herein is a kit including a slow modified release vehicle comprising oral minoxidil or a pharmaceutically acceptable salt thereof.